X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4997) 4997
Book Review (1333) 1333
Publication (368) 368
Book Chapter (95) 95
Conference Proceeding (34) 34
Dissertation (10) 10
Reference (3) 3
Book / eBook (2) 2
Magazine Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3605) 3605
humans (3014) 3014
glucagon-like peptide-1 (1804) 1804
endocrinology & metabolism (1792) 1792
male (1610) 1610
type 2 diabetes (1486) 1486
diabetes mellitus, type 2 - drug therapy (1429) 1429
animals (1425) 1425
incretin (1375) 1375
diabetes (1265) 1265
glucose (1263) 1263
female (1144) 1144
insulin (1071) 1071
glp-1 (945) 945
hypoglycemic agents - therapeutic use (933) 933
incretins (909) 909
glucagon (842) 842
middle aged (829) 829
blood glucose - metabolism (787) 787
adult (753) 753
insulin - metabolism (643) 643
incretins - therapeutic use (606) 606
glycemic control (586) 586
obesity (579) 579
insulin secretion (571) 571
dextrose (569) 569
glucagon-like peptide 1 (564) 564
peptides (539) 539
mice (535) 535
insulin - blood (534) 534
diabetes mellitus, type 2 - blood (525) 525
liraglutide (518) 518
secretion (511) 511
pharmacology & pharmacy (509) 509
gastric-inhibitory polypeptide (491) 491
aged (488) 488
beta-cell function (480) 480
dipeptidyl-peptidase iv inhibitors - therapeutic use (480) 480
type-2 diabetes-mellitus (476) 476
diabetes mellitus (471) 471
diabetes mellitus, type 2 - metabolism (470) 470
glucagon-like peptide 1 - metabolism (466) 466
exenatide (460) 460
incretins - metabolism (455) 455
treatment outcome (450) 450
abridged index medicus (446) 446
rats (437) 437
analysis (429) 429
hypoglycemic agents - adverse effects (422) 422
insulin resistance (421) 421
incretin hormones (420) 420
blood glucose - drug effects (401) 401
internal medicine (391) 391
sitagliptin (388) 388
research (381) 381
glucagon-like peptide-1 receptor (378) 378
metformin (365) 365
hypoglycemic agents - pharmacology (358) 358
insulin-secretion (356) 356
care and treatment (355) 355
gip (352) 352
physiological aspects (352) 352
double-blind (350) 350
physiology (348) 348
hypoglycemic agents - administration & dosage (345) 345
medicine & public health (345) 345
glucagon-like peptide 1 - analogs & derivatives (343) 343
glucose metabolism (337) 337
type 2 diabetes mellitus (335) 335
endocrine system (331) 331
glucagon-like peptide 1 - blood (331) 331
hypoglycemic agents (329) 329
diabetes therapy (325) 325
risk factors (325) 325
hyperglycemia (323) 323
digestive, oral, and skin physiology (321) 321
dipeptidyl peptidase-4 inhibitor (321) 321
health aspects (316) 316
glucagon-like peptide 1 - therapeutic use (314) 314
medicine, general & internal (304) 304
incretin-based therapies (299) 299
drug therapy (291) 291
glucose tolerance test (291) 291
dependent insulinotropic polypeptide (289) 289
hormones, hormone substitutes, and hormone antagonists (289) 289
diabetes mellitus, type 2 - physiopathology (281) 281
hormones (277) 277
diabetes mellitus, type 2 - complications (272) 272
glucose - metabolism (271) 271
mellitus (269) 269
metabolism (252) 252
drug therapy, combination (247) 247
biochemistry & molecular biology (238) 238
insulin-secreting cells - metabolism (234) 234
incretins - pharmacology (233) 233
blood glucose - analysis (231) 231
review (229) 229
bariatric surgery (224) 224
glucagon-like peptide 1 - pharmacology (224) 224
diabetes-mellitus (223) 223
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4657) 4657
German (89) 89
French (64) 64
Spanish (58) 58
Japanese (52) 52
Czech (43) 43
Korean (28) 28
Hungarian (27) 27
Russian (21) 21
Polish (11) 11
Italian (6) 6
Chinese (5) 5
Portuguese (5) 5
Norwegian (4) 4
Danish (3) 3
Croatian (2) 2
Slovak (2) 2
Swedish (2) 2
Romanian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Experimental Neurology, ISSN 0014-4886, 02/2017, Volume 288, pp. 176 - 186
Several single incretin receptor agonists that are approved for the treatment of type 2 diabetes mellitus (T2DM) have been shown to be neuroprotective in cell... 
Glucose-dependent insulinotropic peptide | Incretin | Glucagon-like peptide-1 | Traumatic brain injury | Neurodegeneration | Incretin mimetic
Journal Article
Hormone and Metabolic Research, ISSN 0018-5043, 01/2015, Volume 47, Issue 1, pp. 84 - 87
Abstract The role of incretins in glucose homeostasis is well known. Yet, in recent years, the sustained weight loss and rapid glycemic control following... 
Mini Review | incretins | anti-incretin theory | pancreatic islets | metabolic surgery
Journal Article
Diabetes/Metabolism Research and Reviews, ISSN 1520-7552, 05/2010, Volume 26, Issue 4, pp. 287 - 296
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2016, Volume 18, Issue 5, pp. 491 - 499
Aims: Liraglutide 3.0 mg, an acylated GLP-1 analogue approved for weight management, lowers body weight through decreased energy intake. We conducted... 
body weight | pharmacokinetic | glucagon‐like peptide‐1 | incretin | DIABETIC-PATIENTS | ENERGY | glucagon-like peptide-1 | ENDOCRINOLOGY & METABOLISM | RANDOMIZED-TRIAL | OPEN-LABEL | APPETITE | Overweight - complications | Appetite Depressants - adverse effects | Obesity - drug therapy | Overweight - drug therapy | Humans | Middle Aged | Incretins - pharmacokinetics | Male | Weight Loss - drug effects | Appetite Depressants - therapeutic use | Obesity - blood | Prediabetic State - therapy | Diet, Reducing | Dose-Response Relationship, Drug | Glucagon-Like Peptide-1 Receptor - metabolism | Exercise | Liraglutide - pharmacokinetics | Diabetes Mellitus, Type 2 - therapy | Appetite Depressants - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Body Mass Index | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Obesity - complications | Prediabetic State - complications | Sex Characteristics | Combined Modality Therapy - adverse effects | Overweight - therapy | Overweight - blood | Liraglutide - adverse effects | Incretins - adverse effects | Liraglutide - therapeutic use | Obesity - therapy | Incretins - therapeutic use | Liraglutide - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Incretins - administration & dosage | Appetite Depressants - pharmacokinetics | Cohort Studies | Index Medicus | Original
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2018, Volume 20, Issue 8, pp. 2034 - 2038
This study aimed to quantify the effect of the immediate release (IR) of exenatide, a short‐acting glucagon‐like peptide‐1 (GLP‐1) receptor agonist (GLP‐1RA),... 
pharmacodynamics | 1 analogue | antidiabetic drug | GLP | dose–response relationship | incretin therapy | exenatide | GLP-1 analogue | GLUCAGON-LIKE PEPTIDE-1 | ENDOCRINOLOGY & METABOLISM | dose-response relationship | Incretins - blood | Humans | Intestinal Absorption - drug effects | Glucagon-Like Peptide 1 - blood | Incretins - pharmacokinetics | Diabetes Mellitus, Type 2 - metabolism | Dietary Carbohydrates - metabolism | Systems Biology | Dose-Response Relationship, Drug | Hypoglycemia - prevention & control | Hypoglycemic Agents - blood | Glucagon-Like Peptide-1 Receptor - metabolism | Hypoglycemic Agents - administration & dosage | Postprandial Period | Exenatide - pharmacokinetics | Hypoglycemic Agents - therapeutic use | Digestion - drug effects | Hyperglycemia - prevention & control | Exenatide - therapeutic use | Hypoglycemic Agents - pharmacokinetics | Blood Glucose - analysis | Drug Administration Schedule | Diabetes Mellitus, Type 2 - blood | Gastric Emptying - drug effects | Models, Biological | Drug Liberation | Exenatide - administration & dosage | Exenatide - blood | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Incretins - administration & dosage | Pharmacology | Hypoglycemic agents | Glucose | Glucagon | Dextrose | Gastric emptying | Glutamic acid receptors | Food intake | Index Medicus
Journal Article
Brain Research, ISSN 0006-8993, 2016, Volume 1634, pp. 1 - 11
Abstract The incretins glucagon-like peptide 1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP) are growth factors with neuroprotective... 
Neurology | Incretin | AKT | Neuron | Insulin | Apoptosis | Growth factor
Journal Article
Journal of Parenteral and Enteral Nutrition, ISSN 0148-6071, 2019
Sepsis is characterized by life-threatening organ dysfunction caused by a dysregulated host response to infection and affects over 1 million Americans... 
enteral nutrients | dextrose | inflammation | microbiome | incretin | sepsis
Journal Article
Science Translational Medicine, ISSN 1946-6234, 10/2013, Volume 5, Issue 209, pp. 209ra151 - 209ra151
We report the discovery and translational therapeutic efficacy of a peptide with potent, balanced co-agonism at both of the receptors for the incretin hormones... 
MEDICINE, RESEARCH & EXPERIMENTAL | BODY-WEIGHT | GLYCEMIC CONTROL | HIGH-FAT DIET | GLUCOSE-INTOLERANCE | ENTEROINSULAR AXIS | PANCREATIC BETA-CELLS | DEPENDENT INSULINOTROPIC POLYPEPTIDE | GASTRIC-INHIBITORY POLYPEPTIDE | LIPOPROTEIN-LIPASE | PEPTIDE YY3-36 | CELL BIOLOGY | Acylation - drug effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Middle Aged | Male | Rodentia - metabolism | Weight Loss - drug effects | Hyperglycemia - drug therapy | Young Adult | Incretins - pharmacology | Adult | Female | Gastric Inhibitory Polypeptide - pharmacology | Receptors, Glucagon - agonists | Glucose Tolerance Test | Glucagon-Like Peptide 1 - analogs & derivatives | Glucagon-Like Peptide 1 - pharmacology | Rats | Receptors, Glucagon - metabolism | Treatment Outcome | Haplorhini - metabolism | Gastric Inhibitory Polypeptide - administration & dosage | Peptides - pharmacology | Insulin - metabolism | Animals | Glucagon-Like Peptide-1 Receptor | Adolescent | Aged | Mice | Venoms - pharmacology | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Receptors, Gastrointestinal Hormone | Incretins - administration & dosage | Liraglutide | Index Medicus | Medicin och hälsovetenskap | Medicinsk bioteknologi (inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinsk bioteknologi
Journal Article